Objectives.—To review current knowledge of the biology and clinical implications of human
immunodeficiency virus (HIV) resistance to antiretroviral drugs, describe assays for …

ObjectiveAssays for drug resistance testing in human immunodeficiency virus type 1 (HIV-1)
infection are now available and clinical studies suggest that viral drug resistance is …

New information about the benefits and limitations of testing for resistance to human
immunodeficiency virus (HIV) type 1 (HIV-1) drugs has emerged. The International AIDS …

Assays that detect antiretroviral drug resistance in human immunodeficiency virus have
recently become available to clinicians. Phenotypic assays measure the drug susceptibility …

Background: Antiretroviral therapy has dramatically reduced the morbidity and mortality of
infection due to HIV. The emergence of drug-resistant virus has limited the usefulness of …

To assess the relation between resistance to antiretroviral drugs for treatment of HIV-1
infection and virological response to therapy, results from 12 different studies were re …

Background Among persons in North America who are newly infected with the human
immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs …

ContextThere is concern that the widespread use of antiretroviral drugs to treat human
immunodeficiency virus 1 (HIV-1) infection may result in the increased transmission of drug …

Roger J. Pomerantz, MD THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1)
epidemic, like the virus itself, continues to evolve. Over the last several years, the …

ContextTransmission of multiclass drug-resistant human immunodeficiency virus type 1 (HIV-
1) may increase with wider use of antiretroviral therapy. ObjectiveTo determine trends in …